Clinical Trial Update: Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immunogenicity of Fluzone High Dose in immunocompromised pediatric and young adult populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Stem Cell Transplant Recipient
• Chronic Kidney Disease or Dialysis-dependent Conditions
• Human Immunodeficiency Virus Infection
• Rheumatologic Disorder
• Solid Organ Transplant Recipient

Drugs mentioned

• Fluzone High-Dose (Influenza vaccine, high-dose)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Solid Organ Transplant Recipient (Liver, Kidney, Heart), Rheumatologic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-11-30